478 related articles for article (PubMed ID: 28395201)
21. Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload.
You J; Wu J; Zhang Q; Ye Y; Wang S; Huang J; Liu H; Wang X; Zhang W; Bu L; Li J; Lin L; Ge J; Zou Y
Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H552-H562. PubMed ID: 29196344
[TBL] [Abstract][Full Text] [Related]
22. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
[TBL] [Abstract][Full Text] [Related]
23. Fibroblast GATA-4 and GATA-6 promote myocardial adaptation to pressure overload by enhancing cardiac angiogenesis.
Dittrich GM; Froese N; Wang X; Kroeger H; Wang H; Szaroszyk M; Malek-Mohammadi M; Cordero J; Keles M; Korf-Klingebiel M; Wollert KC; Geffers R; Mayr M; Conway SJ; Dobreva G; Bauersachs J; Heineke J
Basic Res Cardiol; 2021 Apr; 116(1):26. PubMed ID: 33876316
[TBL] [Abstract][Full Text] [Related]
24. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.
Ling H; Zhang T; Pereira L; Means CK; Cheng H; Gu Y; Dalton ND; Peterson KL; Chen J; Bers D; Brown JH
J Clin Invest; 2009 May; 119(5):1230-40. PubMed ID: 19381018
[TBL] [Abstract][Full Text] [Related]
25. Glucose transporter 4-deficient hearts develop maladaptive hypertrophy in response to physiological or pathological stresses.
Wende AR; Kim J; Holland WL; Wayment BE; O'Neill BT; Tuinei J; Brahma MK; Pepin ME; McCrory MA; Luptak I; Halade GV; Litwin SE; Abel ED
Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1098-H1108. PubMed ID: 28822962
[TBL] [Abstract][Full Text] [Related]
26. Extracellular high-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure.
Zhang L; Liu M; Jiang H; Yu Y; Yu P; Tong R; Wu J; Zhang S; Yao K; Zou Y; Ge J
J Cell Mol Med; 2016 Mar; 20(3):459-70. PubMed ID: 26647902
[TBL] [Abstract][Full Text] [Related]
27. Mineralocorticoid Receptor in Smooth Muscle Contributes to Pressure Overload-Induced Heart Failure.
Kim SK; Biwer LA; Moss ME; Man JJ; Aronovitz MJ; Martin GL; Carrillo-Salinas FJ; Salvador AM; Alcaide P; Jaffe IZ
Circ Heart Fail; 2021 Feb; 14(2):e007279. PubMed ID: 33517669
[TBL] [Abstract][Full Text] [Related]
28. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
[TBL] [Abstract][Full Text] [Related]
29. Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure.
Sung MM; Byrne NJ; Kim TT; Levasseur J; Masson G; Boisvenue JJ; Febbraio M; Dyck JR
Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H552-H560. PubMed ID: 28062415
[TBL] [Abstract][Full Text] [Related]
30. Both cardiomyocyte and endothelial cell Nox4 mediate protection against hemodynamic overload-induced remodelling.
Zhang M; Mongue-Din H; Martin D; Catibog N; Smyrnias I; Zhang X; Yu B; Wang M; Brandes RP; Schröder K; Shah AM
Cardiovasc Res; 2018 Mar; 114(3):401-408. PubMed ID: 29040462
[TBL] [Abstract][Full Text] [Related]
31. Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.
Salvador AM; Nevers T; Velázquez F; Aronovitz M; Wang B; Abadía Molina A; Jaffe IZ; Karas RH; Blanton RM; Alcaide P
J Am Heart Assoc; 2016 Mar; 5(3):e003126. PubMed ID: 27068635
[TBL] [Abstract][Full Text] [Related]
32. Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice.
Wu L; Cao Z; Ji L; Mei L; Jin Q; Zeng J; Lin J; Chu M; Li L; Yang X
Biochem Biophys Res Commun; 2017 Feb; 483(2):810-815. PubMed ID: 28013046
[TBL] [Abstract][Full Text] [Related]
33. PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy.
Riehle C; Wende AR; Zaha VG; Pires KM; Wayment B; Olsen C; Bugger H; Buchanan J; Wang X; Moreira AB; Doenst T; Medina-Gomez G; Litwin SE; Lelliott CJ; Vidal-Puig A; Abel ED
Circ Res; 2011 Sep; 109(7):783-93. PubMed ID: 21799152
[TBL] [Abstract][Full Text] [Related]
34. Depletion of β3-adrenergic receptor relieves pressure overload-induced cardiac hypertrophy and heart failure via enhancing innate immune response.
Wei X; Zhang A; Yang W; Fang Y
Biomed Pharmacother; 2021 Nov; 143():112194. PubMed ID: 34563949
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial Integrity and Function in the Progression of Early Pressure Overload-Induced Left Ventricular Remodeling.
Chaanine AH; Sreekumaran Nair K; Bergen RH; Klaus K; Guenzel AJ; Hajjar RJ; Redfield MM
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28619984
[TBL] [Abstract][Full Text] [Related]
37. Endothelial nitric oxide synthase of the bone marrow regulates myocardial hypertrophy, fibrosis, and angiogenesis.
Kazakov A; Müller P; Jagoda P; Semenov A; Böhm M; Laufs U
Cardiovasc Res; 2012 Mar; 93(3):397-405. PubMed ID: 22106415
[TBL] [Abstract][Full Text] [Related]
38. Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy.
Koga K; Kenessey A; Ojamaa K
Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H282-93. PubMed ID: 23144312
[TBL] [Abstract][Full Text] [Related]
39. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
[TBL] [Abstract][Full Text] [Related]
40. Suppressed Production of Soluble Fms-Like Tyrosine Kinase-1 Contributes to Myocardial Remodeling and Heart Failure.
Seno A; Takeda Y; Matsui M; Okuda A; Nakano T; Nakada Y; Kumazawa T; Nakagawa H; Nishida T; Onoue K; Somekawa S; Watanabe M; Kawata H; Kawakami R; Okura H; Uemura S; Saito Y
Hypertension; 2016 Sep; 68(3):678-87. PubMed ID: 27480835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
